These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33310031)

  • 41. Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Harasim E; Górski J
    Adv Med Sci; 2009; 54(1):59-65. PubMed ID: 19403437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diet-induced obese mouse hearts tolerate an acute high-fatty acid exposure that also increases ischemic tolerance.
    Boardman NT; Pedersen TM; Rossvoll L; Hafstad AD; Aasum E
    Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H682-H693. PubMed ID: 32795177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.
    Chuppa S; Liang M; Liu P; Liu Y; Casati MC; Cowley AW; Patullo L; Kriegel AJ
    Kidney Int; 2018 Feb; 93(2):375-389. PubMed ID: 28760335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PPARα agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes.
    Nan WQ; Shan TQ; Qian X; Ping W; Bing GA; Ying LL
    J Endocrinol Invest; 2011 Apr; 34(4):271-5. PubMed ID: 20354356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Asai T; Okumura K; Takahashi R; Matsui H; Numaguchi Y; Murakami H; Murakami R; Murohara T
    Cardiovasc Res; 2006 Jun; 70(3):566-77. PubMed ID: 16546150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PPARalpha agonist induces the accumulation of ceramide in the heart of rats fed high-fat diet.
    Baranowski M; Błachnio A; Zabielski P; Górski J
    J Physiol Pharmacol; 2007 Mar; 58(1):57-72. PubMed ID: 17440226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that activation of nuclear peroxisome proliferator-activated receptor alpha (PPARα) modulates sleep homeostasis in rats.
    Murillo-Rodríguez E; Guzmán K; Arankowsky-Sandoval G; Salas-Crisóstomo M; Jiménez-Moreno R; Arias-Carrión O
    Brain Res Bull; 2016 Oct; 127():156-163. PubMed ID: 27646482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.
    Huang Y; Lang H; Chen K; Zhang Y; Gao Y; Ran L; Yi L; Mi M; Zhang Q
    Appl Physiol Nutr Metab; 2020 Mar; 45(3):227-239. PubMed ID: 31173696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PGC-1α Participates in the Protective Effect of Chronic Intermittent Hypobaric Hypoxia on Cardiomyocytes.
    Gu S; Hua H; Guo X; Jia Z; Zhang Y; Maslov LN; Zhang X; Ma H
    Cell Physiol Biochem; 2018; 50(5):1891-1902. PubMed ID: 30396162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms.
    Wen J; Wang J; Li P; Wang R; Wang J; Zhou X; Zhang L; Li H; Wei S; Cai H; Zhao Y
    Biomed Pharmacother; 2019 Jul; 115():108881. PubMed ID: 31028997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification.
    Fluhr JW; Man MQ; Hachem JP; Crumrine D; Mauro TM; Elias PM; Feingold KR
    J Invest Dermatol; 2009 Feb; 129(2):365-74. PubMed ID: 18704104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
    Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoxia-inducible factor 1 mediates hypoxia-induced cardiomyocyte lipid accumulation by reducing the DNA binding activity of peroxisome proliferator-activated receptor alpha/retinoid X receptor.
    Belanger AJ; Luo Z; Vincent KA; Akita GY; Cheng SH; Gregory RJ; Jiang C
    Biochem Biophys Res Commun; 2007 Dec; 364(3):567-72. PubMed ID: 17963722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Necrostatin-1 reduces cardiac and mitochondrial dysfunction in prediabetic rats.
    Apaijai N; Jinawong K; Singhanat K; Jaiwongkam T; Kerdphoo S; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2021 Aug; 251(1):27-39. PubMed ID: 34265741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carnitine regulates myocardial metabolism by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha) in alcoholic cardiomyopathy.
    Jing L; Zhou LJ; Li WM; Zhang FM; Yuan L; Li S; Song J; Sang Y
    Med Sci Monit; 2011 Jan; 17(1):BR1-9. PubMed ID: 21169901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Auraptene, a citrus peel-derived natural product, prevents myocardial infarction-induced heart failure by activating PPARα in rats.
    Sunagawa Y; Kawaguchi S; Miyazaki Y; Katanasaka Y; Funamoto M; Shimizu K; Shimizu S; Hamabe-Horiike T; Kawase Y; Komiyama M; Mori K; Murakami A; Hasegawa K; Morimoto T
    Phytomedicine; 2022 Dec; 107():154457. PubMed ID: 36223697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats.
    Tanajak P; Sa-Nguanmoo P; Apaijai N; Wang X; Liang G; Li X; Jiang C; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Aug; 35(4):. PubMed ID: 28391633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.